EKF Diagnostics Holdings plc Share Price

Equities

EKF

GB0031509804

Advanced Medical Equipment & Technology

Market Closed - London S.E. 16:35:01 17/07/2024 BST 5-day change 1st Jan Change
30.6 GBX +0.16% Intraday chart for EKF Diagnostics Holdings plc -3.92% -3.32%

Financials

Sales 2024 * 54.68M 71.33M 5.47B Sales 2025 * 58.65M 76.5M 5.86B Capitalization 139M 181M 13.86B
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 2.36 x
Net cash position 2024 * 9.78M 12.75M 978M Net cash position 2025 * 17.1M 22.3M 1.71B EV / Sales 2025 * 2.07 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 317
Yield 2024 *
-
Yield 2025 *
-
Free-Float 94.51%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.81%
1 week-4.86%
Current month+5.59%
1 month+6.89%
3 months+11.20%
6 months-0.65%
Current year-4.26%
More quotes
1 week
30.10
Extreme 30.1
32.50
1 month
27.00
Extreme 27
32.50
Current year
23.00
Extreme 23
34.00
1 year
22.20
Extreme 22.2
34.00
3 years
22.20
Extreme 22.2
86.80
5 years
16.58
Extreme 16.5794
86.80
10 years
7.00
Extreme 7
86.80
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 11/09/23
Chairman 60 25/11/09
Public Communications Contact - 29/02/16
Members of the board TitleAgeSince
Director/Board Member 72 07/04/16
Director/Board Member 49 30/06/21
Chairman 60 25/11/09
More insiders
Date Price Change Volume
17/07/24 30.6 +0.16% 260 882
16/07/24 30.55 -1.77% 330,927
15/07/24 31.1 -0.48% 44,799
12/07/24 31.25 -1.88% 160,866
11/07/24 31.85 0.00% 57,981

Delayed Quote London S.E., July 17, 2024 at 10:00 am

More quotes
EKF Diagnostics Holdings plc is a United Kingdom-based diagnostics company. The Company is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.3055 GBP
Average target price
0.34 GBP
Spread / Average Target
+11.29%
Consensus